Reviewed by Jen Cihlar, DO, Vanderbilt University Medical Center This retrospective cohort study looking at multicenter Vizient Clinical Data Base across the United States, found…

Reviewed by Caitlin Crews-Stowe, PhD, MPH, CPH, CPHQ, VA-BC, CIC   This study looked to evaluate the efficacy of dalbavancin vs standard therapy in 200 patients…

Reviewed by Jose Lucar, MD, FIDSA, The George Washington University Recurrent Clostridioides difficile infections (CDI) are driven by both relapse with the same strain and…

Reviewed by Geeta Sood, Johns Hopkins University This study looked at the efficacy of recombinant herpes zoster vaccine in a 20% random sample of the…

Reviewed by Shipra Gupta, MD, MS, Children’s Hospital at Montefiore Bottomline– A single ESBL-producing E. coli strain caused a severe NEC outbreak via vertical and…

Tracking a Tough Strain: ESBL E. coli Causes NEC Cluster in Preterm Infants High Efficacy with Recombinant Varicella Vaccine The Complexity of Recurrent CDI: Relapse…

Arlington, VA — October 28, 2025— The Society for Healthcare Epidemiology of America (SHEA), in collaboration with the Association for Professionals in Infection Control and…

Reviewed by Clare Marlin, MS, BSN, CIC, Shirley Ryan Ability Lab Catheter-associated urinary tract infections (CAUTIs) may prolong hospitalizations, add medical care costs, and contribute…

Reviewed by Jen Cihlar, DO, Vanderbilt University Medical Center Candida auris screening across 3 LTACHs in Orange County, CA started as a response to an…

Reviewed by Shipra Gupta, MD, MS, Children’s Hospital at Montefiore Bottomline- Nirsevimab protected infants in Western Australia without driving RSV mutations. Genomic and wastewater data…

Armor Without Drama: Nirsevimab Protects Without Driving RSV Mutations Infection Prevention Domino Effect: The Rise of Candida auris during Early COVID-19 From Evidence-Based Practice to…